Home > Recent News >

Nanoparticle Dry Eye Treatment

Summary By: Lori Davila
Date: October 13, 2014


Nanoparticle  Treatment

A ScienceDaily article 'Drug-infused nanoparticle is right for sore eyes', shared insight on a research paper on developments of a new longer term dry eye treatment.

For people with NF2 one of the common issues faced is severs dry eyes from facial nerve damage. This treatment would be a huge relief since dry eyes does not just cause irritation but can potentially cause vision loss due to either repeated cornea damage from multiple incidences of not enough moister or possibly even from even 1 extended duration of lack of moisture. For dry eye sufferers this is a constant serious concern which can result in serious issues from dryness even over just the course of a night.

The treatment, which is currently still in animal trials, is a Mucoadhesive Nanoparticle drug that will not just coat the eye, but bind to the eye itself. This process will allow dry eye suffered who otherwise require eye drops or gel three times a day, to potentially only require application once a week after the eye completely absorbs the last application.

Reference Source

  1. University of Waterloo. (2014, October 8). Drug-infused nanoparticle is right for sore eyes. ScienceDaily. Retrieved October 9, 2014 from http://www.sciencedaily.com/releases/2014/10/141008204021.htm
  2. Liu, S., Chang, C. N., Verma, M. S., Hileeto, D., Muntz, A., Stahl, U., ... & Gu, F. X. (2014). Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome. Nano Research, 1-15. http://link.springer.com/article/10.1007%2Fs12274-014-0547-3